Compare iShares 20 Plus Year Treasury Bond ETF (TLT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 20 Plus Year Treasury Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? iShares 20 Plus Year Treasury Bond ETF trades at $81.42, while Health Care Select Sector SPDR Fund trades at $167.04. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| TLT | XLV | |
|---|---|---|
52-Week High | $92.06 | $175.68 |
52-Week Low | $81.35 | $134.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLT trades at $82.20, down slightly by 0.01% with a bearish technical signal from moving averages. The ETF faces headwinds from rising Treasury yields and potential large-scale selling by institutional investors like Norway's sovereign wealth fund. Recent Treasury buyback announcements of up to $6 billion in long-dated debt provide some support, but the overall trend remains challenging amid inflation concerns and rising oil prices.
The outlook for TLT remains cautious as rising interest rates and inflation pressures continue to weigh on long-duration bonds. While current RSI levels suggest potential oversold conditions, the fundamental environment of higher yields and potential institutional selling creates significant downside risk. Investors should monitor Treasury policy actions and global bond market developments closely.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
